| 40.05 Gy group | 50 Gy group |
---|---|---|
CTV(clinical target volume) | ||
V95 | 99.86 ± 0.13% | 99.72 ± 0.28% |
V99 | 94.37 ± 4.66% | 94.13 ± 4.03% |
Ipsilateral lung | ||
V5 | 23.40 ± 9.73% | 30.72 ± 9.95% |
V10 | 17.08 ± 7.10% | 23.38 ± 8.49% |
V20 | 8.86 ± 4.31% | 13.41 ± 5.91% |
V30 | 3.43 ± 2.36% | 6.63 ± 3.74% |
V40 | 0.31 ± 0.55% | 2.53 ± 1.97% |
V50 | – | 0.28 ± 0.49% |
Dmean | 4.53 ± 1.84 Gy | 6.61 ± 2.52 Gy |
Contralateral lung | ||
V5 | 0.45 ± 0.79% | 2.16 ± 2.17% |
V10 | 0.17 ± 0。01% | 0.92 ± 1.11% |
V20 | 0.03 ± 0.07% | 0.19 ± 0.31% |
V30 | 0.01 ± 0.00% | 0.04 ± 0.09% |
V40 | – | 0.02 ± 0.03% |
V50 | – | – |
Dmean | 0.11 ± 0.13 Gy | 0.39 ± 0.33 Gy |
Heart (left breast cancer) | ||
D2% | 9.09 ± 6.19 Gy | 15.40 ± 9.90 Gy |
V5 | 3.25 ± 1.98% | 4.74 ± 2.87% |
V10 | 1.87 ± 1.29% | 3.09 ± 2.20% |
V20 | 0.71 ± 0.66% | 1.63 ± 0.85% |
V30 | 0.20 ± 0.24% | 0.85 ± 0.31% |
V40 | 0.02 ± 0.04% | 0.31 ± 0.31% |
V45 | – | 0.13 ± 0.03% |
V50 | – | 0.03 ± 0.06% |
Dmean | 0.58 ± 0.33 Gy | 0.98 ± 0.63 Gy |
LAD (left anterior descending artery) | ||
D2% | 17.33 ± 10.98 Gy | 28.59 ± 11.05 Gy |
Dmean | 4.27 ± 3.27 Gy | 4.86 ± 2.42 Gy |